Dec 23 () - A patient who was being treated with Pfizer's hemophilia drug, Hympavzi, as part of a ​long-term study died after experiencing serious side effects, the ‌company said. The individual died on December 14 after suffering a stroke followed by ‌a brain hemorrhage, according to the European Haemophilia Consortium, a patient support group.

The findings potentially solve the paradox of how liquid water seems to have persisted on Mars even when the climate grew too cold.

Israel's parliament approved a law setting the death penalty as the default punishment for Palestinians convicted of deadly attacks.